Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Semin Fetal Neonatal Med. 2007 Apr;12(2):127-33. Epub 2007 Feb 23.

Managing drug withdrawal in the newborn infant.

Author information

  • Auckland District Health Board, Private Bag 92 024, Auckland, New Zealand. carlk@adhb.govt.nz <carlk@adhb.govt.nz>

Abstract

The management of the infant exposed to drugs in utero poses significant challenges. Symptoms and signs of neonatal abstinence syndrome (NAS) are non-specific but most commonly associated with withdrawal from maternal opioids. A high index of suspicion is required when presented with an infant who could be manifesting symptoms of NAS. In the absence of a reliable history of maternal drug exposure, analysis of neonatal meconium or urine may be indicated. Approximately 90% of infants exposed to opioids will exhibit signs of NAS, although a smaller proportion will require pharmacological treatment. Although few studies have evaluated the advantages of different therapeutic agents and strategies, opioid withdrawal is best treated initially with opioid medication. Supportive care of the infant should include assessment of the adequacy of feeding, evaluation of social circumstances (particularly child protection issues) and surveillance for transmission of viral infection.

PMID:
17321815
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk